By: Benzinga
Acura Pharmaceuticals Soars After Launch of New Cold Medicine
A press release on Monday morning has sent shares of Acura Pharmaceuticals (NASDAQ: ACUR ) sharply higher during the trading session. At last check, the stock had added around 64 percent and was trading at $2.36. The company announced the release of a "next generation pseudoephedrine product" which combines
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here